tiprankstipranks
Trending News
More News >
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market

Black Diamond Therapeutics (BDTX) Ownership - Who Owns Black Diamond Therapeutics?

Compare
1,448 Followers

Black Diamond Therapeutics (BDTX) Ownership Overview

19.47%17.79%0.24%7.44%55.05%
19.47% Insiders
0.24% Other Institutional Investors
7.44% ETFs
55.05% Public Companies and
Individual Investors
The ownership structure of Black Diamond Therapeutics (BDTX) stock is a mix of institutional, retail, and individual investors. Approximately 25.48% of the company’s stock is owned by Institutional Investors, 19.47% is owned by Insiders, and 55.05% is owned by Public Companies and Individual Investors.
The ownership structure of Black Diamond Therapeutics (BDTX) stock is a mix of institutional, retail, and individual investors. Approximately 18.03% of the company’s stock is owned by Institutional Investors, 19.47% is owned by Insiders, and 7.44% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 20, 2025
xxxxxxxxxxxxx
$11972369
Aug 30, 2024
xxxxxxxxxxxxx
$1400512

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,206,964Insider10.95%8,813,889
4,519,737Insider7.98%6,418,027
2,733,547Insider4.82%3,881,637
2,424,301Institution4.28%3,442,507
2,372,649Institution4.19%3,369,162
2,148,081Institution3.79%3,050,275
1,930,139Institution3.41%2,740,797
1,509,999Institution2.66%2,144,199
1,236,268Institution2.18%1,755,501
555,111Institution0.98%788,258

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,424,301Institution4.28%3,442,507
2,372,649Institution4.19%3,369,162
1,930,139Institution3.41%2,740,797
1,236,268Institution2.18%1,755,501
447,989Institution0.79%636,144
421,176Institution0.74%598,070
251,199Institution0.44%356,703
221,716Institution0.39%314,837
142,000Institution0.25%201,640
109,224Institution0.19%155,098

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,329,831Institution2.35%2,672,960
1,017,689Institution1.80%1,445,118
600,308Institution1.06%1,206,619
253,432Institution0.45%359,873
247,406Institution0.44%346,368
181,585Institution0.32%364,986
114,891Institution0.20%163,145
87,851Institution0.16%124,748
82,055Institution0.14%114,056
68,533Institution0.12%95,261

FAQ

Who Owns Black Diamond Therapeutics (BDTX)?
According to the latest TipRanks data, approximately 0.24% of the company's stock is held by institutional investors, 19.47% is held by insiders, and 55.05% is held by retail investors.
    What percentage of Black Diamond Therapeutics (BDTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.24% of Black Diamond Therapeutics (BDTX) stock is held by institutional investors.
      What percentage of Black Diamond Therapeutics (BDTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 55.05% of Black Diamond Therapeutics (BDTX) stock is held by retail investors.
        Who owns the most shares of Black Diamond Therapeutics (BDTX)?
        Versant Venture Capital VI, L.P. owns the most shares of Black Diamond Therapeutics (BDTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis